Liquidia extends gains as Raymond James upgrades on Yutrepia launch
at seekingalpha.com (Wed, 11-Nov 10:46 AM)
at www.tipranks.com (Wed, 11-Nov 5:50 AM)
BTIG Reaffirms Their Buy Rating on Liquidia Technologies (LQDA)
at www.tipranks.com (Wed, 11-Nov 5:38 AM)
Wells Fargo Sticks to Its Hold Rating for Liquidia Technologies (LQDA)
at www.tipranks.com (Wed, 11-Nov 5:38 AM)
Liquidia Faces Financing Strain as YUTREPIA Restrictions Threaten Revenue and Strategic Flexibility
at www.tipranks.com (Wed, 11-Nov 1:01 AM)
Liquidia Technologies Earnings Call Signals Strong Growth
at www.tipranks.com (Tue, 10-Nov 7:10 PM)
Liquidia Reports Strong Third-Quarter YUTREPIA Sales Growth
at www.tipranks.com (Tue, 10-Nov 7:36 AM)
Liquidia GAAP EPS of -$2.64 misses by $3.60, revenue of $225.3M beats by $11.15M
at seekingalpha.com (Tue, 10-Nov 6:36 AM)
Here are the major earnings before the open Tuesday
at seekingalpha.com (Mon, 9-Nov 6:00 PM)
Liquidia Q3 2026 Earnings Preview
at seekingalpha.com (Mon, 9-Nov 10:08 AM)
Liquidia Sets Nov. 10 Webcast to Detail Q3 2026 Results and Provide a Corporate Update
Market Chameleon (Tue, 3-Nov 9:21 AM)
Liquidia Rallies to $34.05 as Investor Probe Revives Focus on the Yutrepia Patent Setback
Market Chameleon (Wed, 14-Oct 10:27 AM)
Market Chameleon (Tue, 13-Oct 11:28 AM)
Liquidia Faces Partial '327 Patent Loss as Court Finds Two Claims Valid and Infringed
Market Chameleon (Thu, 1-Oct 7:10 AM)
Liquidia Reports Surging Profitability on YUTREPIA Sales and Clinical Milestones in Q2 2026
Market Chameleon (Wed, 12-Aug 7:08 AM)
